U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07721935) titled 'Development of an AI-Agent for Urological Disease Diagnosis and Treatment' on July 12.
Brief Summary: Urological diseases such as urinary stones, prostate cancer, and bladder cancer are very common and often require highly specialized diagnosis and treatment. Today, the quality of care can vary between doctors, and there are not enough urology specialists to meet patient demand. Artificial intelligence (AI) may help doctors make faster and more consistent decisions.
This study aims to develop and test an AI-powered assistant called "UroAgent" that supports doctors in diagnosing and treating urological diseases. UroAgent is built on...